{"id":68844,"date":"2023-01-19T23:08:59","date_gmt":"2023-01-19T22:08:59","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?page_id=68844"},"modified":"2026-03-05T11:11:49","modified_gmt":"2026-03-05T10:11:49","slug":"unblindedpod","status":"publish","type":"page","link":"https:\/\/pantheon.veeva.com\/eu\/unblindedpod\/","title":{"rendered":"State of Digital Clinical Trials Podcast"},"content":{"rendered":"<style>\n\t.product-banner-hero {\n\t\tdisplay: none;\n\t}<\/p>\n<p>\t.podcast-hero {\n\t\tbackground-color: #1B2F54;\n\t}<\/p>\n<p>\t.podcast-hero p {\n\t\tmargin-top: 15px;\n\t}<\/p>\n<p>\t@media screen and (max-width: 991px) {\n\t\t.podcast-hero p {\n\t\t\tmargin-top: 0px;\n\t\t}\n\t}<\/p>\n<p>\t@media screen and (max-width: 870px) {\n\t\t.podcast-hero p {\n\t\t\tmargin-top: 20px;\n\t\t}\n\t}<\/p>\n<p>\t.container.bg {\n\t\tbackground-image: url('https:\/\/www.veeva.com\/wp-content\/uploads\/2022\/12\/Hero-banner-graphic-1.png');\n\t\tbackground-repeat: no-repeat;\n\t\tbackground-position: center right;\n\t\theight: 128px;\n\t\tcolor: #fff;\n\t}<\/p>\n<p>\t.podcast-hero .pod-banner {\n\t\tpadding: 27px 0;\n\t\tdisplay: flex;\n\t}<\/p>\n<p>\t.pod-banner .icons {\n\t\tmargin-top: auto;\n\t\ttext-align: right;\n\t\tline-height: 18px;\n\t\twhite-space: nowrap\n\t}<\/p>\n<p>\t.icons img {\n\t\theight: 20px;\n\t}<\/p>\n<p>\t.icons a {\n\t\tpadding: 0 20px 0 12px;\n\t\tcolor: #fff;\n\t\tfont-weight: 400;\n\t}<\/p>\n<p>\t.icons a:hover {\n\t\tcolor: #f69921;\n\t}<\/p>\n<p>\t.icons br {\n\t\tdisplay: none;\n\t}<\/p>\n<p>\t@media screen and (max-width: 870px) {\n\t\t.col-sm-6 {\n\t\t\twidth: 100%;\n\t\t}<\/p>\n<p>\t\t.container.bg {\n\t\t\theight: auto;\n\t\t}<\/p>\n<p>\t\t.podcast-hero .pod-banner {\n\t\t\tpadding: 27px 0;\n\t\t\tdisplay: block;\n\t\t}<\/p>\n<p>\t\t.pod-banner .icons {\n\t\t\tpadding-top: 20px;\n\t\t\ttext-align: left;\n\t\t\tpadding-left: 83px;\n\t\t}\n\t}<\/p>\n<p>\t@media screen and (max-width: 500px) {\n\t\t.pod-banner .icons {\n\t\t\tline-height: 34px;\n\t\t\tpadding-left: 70px;\n\t\t}<\/p>\n<p>\t\t.icons br {\n\t\t\tdisplay: block;\n\t\t}\n\t}<\/p>\n<p>\t.top-pod .text {\n\t\tfont-size: 18px;\n\t\tline-height: 26px;\n\t\tmargin-bottom: 20px;\n\t}<\/p>\n<p>\t.top-pod .d-flex,\n\t.main-pod .d-flex {\n\t\tdisplay: flex;\n\t\talign-items: center;\n\t}<\/p>\n<p>\t.top-pod a,\n\t.main-pod a {\n\t\tdisplay: block;\n\t\tfont-size: 18px;\n\t\tfont-weight: 500;\n\t\tcursor: pointer;\n\t}<\/p>\n<p>\t.top-pod .text span {\n\t\t\/* color:#F69C24; *\/\n\t\tcolor: #999;\n\t\tfont-weight: 500;\n\t}<\/p>\n<p>\t.top-pod .text h1 {\n\t\tfont-size: 26px;\n\t\tline-height: 32px;\n\t\tmargin: 8px 0;\n\t\tfont-weight: 500;\n\t}<\/p>\n<p>\t.main-pod .text span {\n\t\tfont-weight: 500;\n\t\t\/* color:#F69C24; *\/\n\t\tcolor: #999;\n\t}<\/p>\n<p>\t.main-pod .seasons {\n\t\tdisplay: flex;\n\t}<\/p>\n<p>\t.main-pod h2 {\n\t\tmargin: 0;\n\t\tfont-weight: 500;\n\t\tcursor: pointer;\n\t}<\/p>\n<p>\t@media (max-width: 767px) {\n\t\t.seasons h2 {\n\t\t\tfont-size: 16px;\n\t\t\tline-height: 20px;\n\t\t}\n\t}<\/p>\n<p>\t@media (max-width: 415px) {\n\t\t.seasons h2 {\n\t\t\tfont-size: 13px;\n\t\t\tline-height: 16px;\n\t\t}\n\t}<\/p>\n<p>\t.main-pod h2.season-4-btn {\n\t\tpadding-right: 20px;\n\t}<\/p>\n<p>\t@media (max-width: 767px) {\n\t\t.main-pod h2.season-4-btn {\n\t\t\tpadding-right: 10px;\n\t\t}\n\t}<\/p>\n<p>\t.main-pod h2.season-3-btn,\n\t.main-pod h2.season-2-btn {\n\t\tpadding-right: 20px;\n\t\tpadding-left: 20px;\n\t\tborder-left: 1px solid #eeeeee;\n\t}<\/p>\n<p>\t@media (max-width: 767px) {\n\t\t.main-pod h2.season-3-btn,\n\t\t.main-pod h2.season-2-btn {\n\t\t\tpadding-right: 10px;\n\t\t\tpadding-left: 10px;\n\t\t}\n\t}<\/p>\n<p>\t.main-pod h2.season-1-btn {\n\t\tpadding-left: 20px;\n\t\tborder-left: 1px solid #eeeeee;\n\t}<\/p>\n<p>\t@media (max-width: 767px) {\n\t\t.main-pod h2.season-1-btn {\n\t\t\tpadding-left: 10px;\n\t\t}\n\t}<\/p>\n<p>\t.main-pod h2.active {\n\t\tcolor: #f69921;\n\t}<\/p>\n<p>\t.main-pod .text h2 {\n\t\tmargin: 15px 0;\n\t\tfont-weight: 400;\n\t\tmargin-bottom: 0;\n\t}<\/p>\n<p>\t.main-pod .text p {\n\t\tmargin-top: 15px;\n\t}<\/p>\n<p>\t.main-pod hr {\n\t\tmargin-top: 15px;\n\t\tmargin-bottom: 50px;\n\t}<\/p>\n<p>\t.main-pod img {\n\t\tborder-radius: 10px;\n\t}<\/p>\n<p>\t@media screen and (max-width: 991px) {\n\t\t.top-pod .d-flex {\n\t\t\tdisplay: block;\n\t\t\talign-items: center;\n\t\t}<\/p>\n<p>\t\t.main-pod .d-flex {\n\t\t\talign-items: start;\n\t\t}<\/p>\n<p>\t\t.top-pod .text {\n\t\t\tfont-size: 18px;\n\t\t\tline-height: 26px;\n\t\t\tpadding-top: 20px;\n\t\t\tmargin-bottom: 15px;\n\t\t}<\/p>\n<p>\t\t.top-pod .text h1 {\n\t\t\tfont-size: 26px;\n\t\t\tline-height: 32px;\n\t\t\tmargin: 6px 0;\n\t\t\tfont-weight: 500;\n\t\t}\n\t}<\/p>\n<p>\t@media screen and (max-width: 767px) {<\/p>\n<p>\t\t.top-pod .d-flex,\n\t\t.main-pod .d-flex {\n\t\t\tdisplay: block;\n\t\t}<\/p>\n<p>\t\t.top-pod .text {\n\t\t\tfont-size: 16px;\n\t\t\tline-height: 23px;\n\t\t}<\/p>\n<p>\t\t.top-pod .text h1 {\n\t\t\tfont-size: 24px;\n\t\t\tline-height: 29px;\n\t\t}<\/p>\n<p>\t\t.main-pod .text-box {\n\t\t\tmax-width: 405px;\n\t\t\tmargin: auto;\n\t\t}<\/p>\n<p>\t\t.product-container.main-pod .img-responsive {\n\t\t\tmargin: auto;\n\t\t\tmargin-bottom: 20px;\n\t\t}<\/p>\n<p>\t\t.main-pod .mb-50 {\n\t\t\tmargin-bottom: 30px !important;\n\t\t}\n\t}<\/p>\n<p>\t.dct .main-txt {\n\t\tfont-size: 24px;\n\t\tline-height: 34px;\n\t\tfont-weight: 300;\n\t}<\/p>\n<p>\t.dct .icons a {\n\t\tpadding: 10px 20px 0 12px;\n\t\tcolor: #444;\n\t\tfont-weight: 400;\n\t}<\/p>\n<p>\t.dct .icons a:hover {\n\t\tcolor: #f69921;\n\t}<\/p>\n<p>\t.dct hr {\n\t\tborder-color: #D5D5D9;\n\t\tmargin: 20px 0;\n\t}<\/p>\n<p>\t@media screen and (max-width: 767px) {\n\t\t.dct .main-txt {\n\t\t\tfont-size: 20px;\n\t\t\tline-height: 30px;\n\t\t\tfont-weight: 300;\n\t\t}<\/p>\n<p>\t\t.dct .img-responsive {\n\t\t\tmargin: auto;\n\t\t\tmargin-bottom: 15px;\n\t\t}<\/p>\n<p>\t\t.dct .icons a {\n\t\t\tpadding: 20px 20px 0 12px;\n\t\t\tfont-size: 16px;\n\t\t}\n\t}<\/p>\n<p>\t.scrolldown {\n\t\tposition: absolute;\n\t\tmargin-top: -150px;\n\t}<\/p>\n<p>\t.season-1,\n\t.season-2,\n\t.season-3 {\n\t\tdisplay: none;\n\t}<\/p>\n<p>\ta.inline-block {\n\t\tdisplay: inline;\n\t\tfont-weight: 300;\n\t}\n<\/style>\n<p><script>\n\tfunction findPos(obj) {\n\t\tvar curtop = 0;\n\t\tif (obj.offsetParent) {\n\t\t\tdo {\n\t\t\t\tcurtop += obj.offsetTop;\n\t\t\t} while (obj = obj.offsetParent);\n\t\t\treturn [curtop];\n\t\t}\n\t}<\/p>\n<p>\t$(document).ready(function () {\n\t\t$('.season-1-btn').click(function () {\n\t\t\tif (!$('.season-1-btn').hasClass('active')) {\n\t\t\t\t$('.season-1-btn').addClass('active');\n\t\t\t}\n\t\t\t$('.season-2-btn').removeClass('active');\n\t\t\t$('.season-3-btn').removeClass('active');\n\t\t\t$('.season-4-btn').removeClass('active');\n\t\t\t$('.season-1').show();\n\t\t\t$('.season-2').hide();\n\t\t\t$('.season-3').hide();\n\t\t\t$('.season-4').hide();\n\t\t});\n\t\t$('.season-2-btn').click(function () {\n\t\t\tif (!$('.season-2-btn').hasClass('active')) {\n\t\t\t\t$('.season-2-btn').addClass('active');\n\t\t\t}\n\t\t\t$('.season-1-btn').removeClass('active');\n\t\t\t$('.season-3-btn').removeClass('active');\n\t\t\t$('.season-4-btn').removeClass('active');\n\t\t\t$('.season-1').hide();\n\t\t\t$('.season-2').show();\n\t\t\t$('.season-3').hide();\n\t\t\t$('.season-4').hide();\n\t\t});\n\t\t$('.season-3-btn').click(function () {\n\t\t\tif (!$('.season-3-btn').hasClass('active')) {\n\t\t\t\t$('.season-3-btn').addClass('active');\n\t\t\t}\n\t\t\t$('.season-1-btn').removeClass('active');\n\t\t\t$('.season-2-btn').removeClass('active');\n\t\t\t$('.season-4-btn').removeClass('active');\n\t\t\t$('.season-1').hide();\n\t\t\t$('.season-2').hide();\n\t\t\t$('.season-4').hide();\n\t\t\t$('.season-3').show();\n\t\t});\n\t\t$('.season-4-btn').click(function () {\n\t\t\tif (!$('.season-4-btn').hasClass('active')) {\n\t\t\t\t$('.season-4-btn').addClass('active');\n\t\t\t}\n\t\t\t$('.season-1-btn').removeClass('active');\n\t\t\t$('.season-2-btn').removeClass('active');\n\t\t\t$('.season-3-btn').removeClass('active');\n\t\t\t$('.season-1').hide();\n\t\t\t$('.season-2').hide();\n\t\t\t$('.season-3').hide();\n\t\t\t$('.season-4').show();\n\t\t});<\/p>\n<p>\t\tvar hash = window.location.hash.substring(1);\n\t\tif ((hash == 'episode-1') || (hash == 'Episode-1')) { hash = 's1-e1'; }\n\t\tif ((hash == 'episode-2') || (hash == 'Episode-2')) { hash = 's1-e2'; }\n\t\tif ((hash == 'episode-3') || (hash == 'Episode-3')) { hash = 's1-e3'; }\n\t\tif ((hash == 'episode-4') || (hash == 'Episode-4')) { hash = 's1-e4'; }\n\t\tif ((hash == 'episode-5') || (hash == 'Episode-5')) { hash = 's1-e5'; }\n\t\tif ((hash == 'episode-6') || (hash == 'Episode-6')) { hash = 's1-e6'; }\n\t\tif ((hash == 'episode-7') || (hash == 'Episode-7')) { hash = 's1-e7'; }\n\t\tif ((hash == 'episode-8') || (hash == 'Episode-8')) { hash = 's1-e8'; }\n\t\tif ((hash == 'episode-9') || (hash == 'Episode-9')) { hash = 's1-e9'; }\n\t\tif ((hash == 'episode-10') || (hash == 'Episode-10')) { hash = 's1-e10'; }\n\t\tif (new RegExp(\"s1-\").test(hash)) {\n\t\t\t$('.season-2-btn').removeClass('active');\n\t\t\t$('.season-1-btn').addClass('active');\n\t\t\t$('.season-1').show();\n\t\t\t$('.season-2').hide();\n\t\t\tsetTimeout(function () {\n\t\t\t\twindow.scroll({\n\t\t\t\t\ttop: findPos(document.getElementById(hash)),\n\t\t\t\t\tleft: 0,\n\t\t\t\t\tbehavior: 'smooth'\n\t\t\t\t});\n\t\t\t}, 500);\n\t\t} else if (new RegExp(\"s2-\").test(hash)) {\n\t\t\t$('.season-1-btn').removeClass('active');\n\t\t\t$('.season-2-btn').addClass('active');\n\t\t\t$('.season-1').hide();\n\t\t\t$('.season-2').show();\n\t\t\tsetTimeout(function () {\n\t\t\t\twindow.scroll({\n\t\t\t\t\ttop: findPos(document.getElementById(hash)),\n\t\t\t\t\tleft: 0,\n\t\t\t\t\tbehavior: 'smooth'\n\t\t\t\t});\n\t\t\t}, 500);\n\t\t}\n\t});\n<\/script><\/p>\n<div class=\"podcast-hero\">\n<div class=\"container bg\">\n<div class=\"row pod-banner text-left\">\n<div class=\"col-sm-6\">\n\t\t\t\t\t<img decoding=\"async\" style=\"max-height:72px\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2025\/08\/Unblinded-a-clinical-trial-podcast-logo-for-web-page-header@2x.png\">\n\t\t\t\t<\/div>\n<div class=\"col-sm-6\">\n<p class=\"white\">Get in touch with us if you would like to contribute to the podcast or share your feedback <strong><a href=\"mailto:unblindedpod@veeva.com\">unblindedpod@veeva.com<\/a><\/strong><\/p>\n<\/div>\n<div class=\"col-sm-6 icons hidden\">\n\t\t\t\t<img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/12\/Spotify-icon.png\"><a target=\"_blank\" href=\"https:\/\/open.spotify.com\/show\/2zIGPSf4Uw3s7qOHA39ykD\" rel=\"noopener\">Spotify<\/a><br \/>\n\t\t\t\t<img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/12\/Apple-podcast.png\"><a target=\"_blank\" href=\"https:\/\/podcasts.apple.com\/us\/podcast\/state-of-digital-clinical-trials-podcast\/id1634250410\" rel=\"noopener\">Apple Podcasts<\/a> <br \/>\n\t\t\t\t<img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/12\/YouTube-Icon.png\"><a target=\"_blank\" href=\"https:\/\/www.youtube.com\/playlist?list=PLPRDETVDFr08j0kP0dEWL32z4_0JsiviT\" rel=\"noopener\">Youtube<\/a>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"product-container top-pod\" style=\"background-color:#F2F2F2\">\n<div class=\"container\">\n<div class=\"row\">\n<div class=\"col-md-7 col-lg-8\">\n                                  <script>\n\t\t\twindow._wq = window._wq || [];\n\t\t\t_wq.push({\n\t\t\t  id: \"5qbil91uwa\",\n\t\t\t  options: {\n\t\t\t\tplugin: {\n\t\t\t\t  \"captions\": {\n\t\t\t\t\tonByDefault: false\n\t\t\t\t  }\n\t\t\t\t}\n\t\t\t  }\n\t\t\t});\n\t\t\t<\/script><script src=\"https:\/\/fast.wistia.com\/embed\/medias\/5qbil91uwa.jsonp\" async><\/script><script src=\"https:\/\/fast.wistia.com\/assets\/external\/E-v1.js\" async><\/script><div class=\"wistia_responsive_padding\" style=\"padding:56.25% 0 0 0;position:relative;\"><div class=\"wistia_responsive_wrapper\" style=\"height:100%;left:0;position:absolute;top:0;width:100%;\"><div class=\"wistia_embed wistia_async_5qbil91uwa videoFoam=true\" style=\"height:100%;position:relative;width:100%\"><div class=\"wistia_swatch\" style=\"height:100%;left:0;opacity:0;overflow:hidden;position:absolute;top:0;transition:opacity 200ms;width:100%;\"><img decoding=\"async\" src=\"https:\/\/fast.wistia.com\/embed\/medias\/5qbil91uwa\/swatch\" style=\"filter:blur(5px);height:100%;object-fit:contain;width:100%;\" alt=\"\" aria-hidden=\"true\" onload=\"this.parentNode.style.opacity=1;\" \/><\/div><\/div><\/div><\/div>\n                       <\/div>\n<div class=\"col-md-5 col-lg-4 text-left\">\n<div class=\"text\">\n\t\t\t\t\t<span>Season 4 Episode 7<\/span><\/p>\n<h1>The Economics of Clinical Trial Outsourcing<\/h1>\n<p>Joel White, owner of Marketcap Consulting, together with Veeva\u2019s Chris Kreitel, joins Manny to discuss why the next era of clinical trial outsourcing will be defined by technology integration and economic agility. They debate whether CROs are the ultimate masters of integrating tech, and the role of small biotechs as growth drivers in the market.<\/p>\n<\/p><\/div>\n<div class=\"wistia_embed wistia_async_5qbil91uwa popover=true popoverContent=link\">\n\t\t\t\t\t<a href=\"\" class=\"after-arrow-orange\">Watch Video<\/a>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div class=\"product-container main-pod\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-sm-12\">\n<div class=\"seasons mb-10\">\n<h2 class=\"season-4-btn active\">Season 4<\/h2>\n<h2 class=\"season-3-btn\">Season 3<\/h2>\n<h2 class=\"season-2-btn\">Season 2<\/h2>\n<h2 class=\"season-1-btn\">Season 1<\/h2>\n<\/p><\/div>\n<hr><\/div>\n<\/p><\/div>\n<div class=\"season-4\">\n<p>                        <a id=\"s4-e6\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_85ne519zkv popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2026\/03\/unblinded-a-clinical-trial-podcast-social-image-a-people-focused-approach-website-thumbnail-episode-6-340x240@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 6<\/span><\/p>\n<h2>A People-Focused Approach to a Risk-Based Future in Clinical Trials<\/h2>\n<p>\n\t\t\t\t\t\tIn this episode, host Manny Vazquez is joined by Noeleen Turner, head of clinical data management at UCB, and Anna Hayes, senior director of clinical data management at Veramed. Using their breadth of experience and passion for a people-focused approach to clinical trial advancement, together they dive into hot topics like risk-based data management, the intricacies of change management in clinical data, and the growing importance of endpoint-driven design.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_85ne519zkv popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>                        <a id=\"s4-e5\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_lnsl8ufvxg popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2026\/01\/unblinded-a-clinical-trial-podcast-social-image-shifting-the-paradigm-website-thumbnail-340x240@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 5<\/span><\/p>\n<h2>ICH E6(R3): Shifting the Paradigm from Process to Purpose<\/h2>\n<p>\n\t\t\t\t\t\tIn this episode, we pull back the curtain on the monumental effort required to reshape global clinical trial standards. Manny and guests Lisbeth Bregnhoj and Cheryl Grandinetti explore why ICH E6(R3) is the catalyst the industry has been waiting for.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_pc0qgw1eva popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>                        <a id=\"s4-e4\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_lnsl8ufvxg popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2026\/01\/unblinded-a-clinical-trial-podcast-social-image-a-people-focused-approach-website-thumbnail-Lengfellner-340x240@2x-1.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 4<\/span><\/p>\n<h2>The Unstuck Industry: A New Equitable Model for Pharma<\/h2>\n<p>\n\t\t\t\t\t\tBrian Johnson, former head of R&#038;D technology at Takeda, now consultant, shares his unique perspective on a topic that\u2019s top-of-mind for many: how do you introduce new technologies and processes without alienating the people who need them most? He and Manny also tackle the critical issue of health equity, examining how technology can help diversify clinical trials and, in turn, create a more equitable future for all. Join us as we explore the business case for change and the crucial steps needed to unstick the industry from its current trajectory.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_lnsl8ufvxg popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>                        <a id=\"s4-e3\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_rj28am8wtb popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2025\/12\/unblinded-a-clinical-trial-podcast-social-image-a-people-focused-approach-website-thumbnail-Lengfellner-340x240@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 3<\/span><\/p>\n<h2>Innovation from the Inside: How Sites Are Redefining Clinical Research<\/h2>\n<p>\n\t\t\t\t\t\t\tManny is joined by co-host Denali Rose and MSKCC\u2019s Joe Lengfellner, to discuss the shifting focus from a one-size-fits-all approach to redefine site centricity. They talk about how the role of a clinical trial coordinator is changing, the challenges of managing data and protocol amendments across different systems, and the promise of technologies like EHR-to-EDC to streamline workflows.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_rj28am8wtb popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>                          <a id=\"s4-e2\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_bcacj401ht popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2025\/11\/resource-tile-unblinded-a-clinical-trial-podcast-s4-e2-340x240@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 2<\/span><\/p>\n<h2>Patient vs. Process: Bridging the Gap for a Better Trial Experience<\/h2>\n<p>\n\t\t\t\t\t\t\tJoin host Manny Vazquez as he sits down with Joyce Moore, leading voice in patient recruitment with over 25 years of experience in the industry, most recently at Allucent. In a field often focused on the logistics of data collection and study processes, Joyce offers a crucial perspective: seeing patients not as subjects, but as collaborators. She and Manny discuss the delicate balance of collecting essential data for clinical endpoints without overwhelming patients. <\/p>\n<p><em>Recorded at R&#038;D and Quality Summit 2025 in Madrid.<\/em><\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_bcacj401ht popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s4-e1\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_s4yys2kn7f popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2025\/10\/Unblinded-a-clinical-trial-podcast-season-4-episode-1-website-thumbnail-384x216@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 1<\/span><\/p>\n<h2>Biggest Risks (and Possible Rewards) of AI in Clinical Data<\/h2>\n<p>\n\t\t\t\t\t\t\tAre we any closer to working out the human-machine relationship needed to embed AI in clinical development? To discuss this and all things automation, Veeva\u2019s Chief Technology Officer Drew Garty joins host Manny Vazquez as he kicks off the new season with two innovators in the industry: Doug Bain, founder and consulting partner at Clinflo, and Robert Bergann, clinical digital innovation leader at Bayer.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_s4yys2kn7f popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"season-3\">\n\t\t\t<a id=\"s3-e5\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_s4yys2kn7f popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2024\/12\/State-of-digital-clinical-trials-podcast-S3-E5-thumbnail@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 5<\/span><\/p>\n<h2>Is a Heavy Tech Burden the Price of Progress for Sites?<\/h2>\n<p>\n\t\t\t\t\t\t\tRichard Young passes the torch to Manny Vazquez, our new podcast host, and shares his reflections before turning off his mic for the final time. Later, Manny is joined by renowned industry thinker and site leader Brad Hightower, owner of clinical research center Hightower Clinical in Oklahoma. They discuss whether the growing tech burden is the price of progress for sites, plus tips on how sponsors can make sites\u2019 lives easier. Brad also explains a few implications of the recent FDA draft guidance on DCTs and the upcoming site conference he helped to set up, &#8216;Save our Sites&#8217;.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_s4yys2kn7f popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s3-e4\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_gh0usj6nwa popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/10\/State-of-digital-clinical-trials-podcast-S3-E4-thumbnail@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 4<\/span><\/p>\n<h2>AI and Clinical Transformation: High-Value or Hype?<\/h2>\n<p>\n\t\t\t\t\t\t\tNovo Nordisk\u2019s Vice President for Clinical Data Operations and Insights Ibrahim Kamstrup-Akkaoui joins Richard this week&#8217;s episode. As Ibrahim explains, the pace of innovation in clinical development is accelerating, sometimes generating billions of relevant data points for study teams to manage. AI is already adding value and can help organizations sustainably manage this growth. They discuss how to start small and think big with AI and concrete examples of where it is delivering for Novo Nordisk, such as generating meaningful test data and study builds.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_gh0usj6nwa popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s3-e3\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_2fn8kwvvep popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/10\/State-of-digital-clinical-trials-podcast-S3-E3-thumbnail@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 3<\/span><\/p>\n<h2>Does Data Science Require Data Perfection?<\/h2>\n<p>\n\t\t\t\t\t\t\tPfizer\u2019s Vice President for Data Monitoring and Management Demetris Zambas joins Richard to discuss the evolution of data science, the potential applications of AI, and whether we still need to strive for data perfection. Although the tools have changed, the mission and successful traits of a strong data scientist remain consistent \u2014 and could soon be enhanced by an AI assistant.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_2fn8kwvvep popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s3-e2\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_odnyj7fj0o popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/10\/State-of-digital-clinical-trials-podcast-S3-E2-thumbnail@2x.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 2<\/span><\/p>\n<h2>The Launch of Boehringer Ingelheim&#8217;s One Medicine Platform<\/h2>\n<p>\n\t\t\t\t\t\t\tNicole Raleigh hosts this special episode on-site from Boehringer Ingelheim\u2019s Human Pharmacology Center in Biberach, Germany. Andrea Kloeble and Daniel Schwenk are part of the team reimagining drug development at Boehringer Ingelheim through the One Medicine Platform. And Richard is in the guest seat this week to put this transformative initiative into industry context: as he explains, life sciences is no longer willing to accept single-use data.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_odnyj7fj0o popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s3-e1\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_kt5azsq5fn popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/09\/State-of-digital-clinical-trials-podcast-S3-E1-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 1<\/span><\/p>\n<h2>Against All Odds: Finding a Treatment for SPG50<\/h2>\n<p>\n\t\t\t\t\t\t\tIn a deeply personal and moving episode, two patient advocates share their stories of working tirelessly to deliver safe and effective gene therapy for children suffering from spastic paraplegia 50 (SPG50). <\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_kt5azsq5fn popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/div>\n<div class=\"season-2\">\n<a id=\"s2-e9\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_zoxj9rtibf popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/09\/State-of-digital-clinical-trials-podcast-S2-E9-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 9<\/span><\/p>\n<h2>Are We Too Risk Averse in Clinical Research?<\/h2>\n<p>\t\t\t\t\t\t<strong>TGuest: Ken Getz, Executive Director and Research Professor, Tufts Center for the Study of Drug Development<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tThis week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development. In this episode, Richard and Ken debate whether clinical research is striking the right balance in its approach to risk and innovation, the problem-solving role played by sites, and CISCRP\u2019s work to improve public trust in scientific advances.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_zoxj9rtibf popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s2-e8\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_hbi79dj8gz popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2024\/05\/S2E8-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 8<\/span><\/p>\n<h2>Putting Patient Data at the Heart of Your Strategy<\/h2>\n<p>\t\t\t\t\t\t<strong>Terttu Haring, president of sites and patients, Syneos Health <br \/>\n                                                                  Leonie Christianson, director, R&#038;D advisory, Syneos Health<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tIn this episode, Richard Young speaks with Terttu Haring and Leonie Christianson from Syneos Health. Nowadays, clinical data managers have the tools to collect insights from large volumes of data. But has this influx of data and tech caused us to move farther away from the patients we serve? This episode outlines the major opportunities for life sciences organizations to put patients back at the heart of clinical strategy.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_hbi79dj8gz popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s2-e7\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_ioau0ndex9 popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/05\/S2E7-website-thumbnail-1.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 7<\/span><\/p>\n<h2>Sites Are Voicing Their Concerns, But Are We Listening?<\/h2>\n<p>\t\t\t\t\t\t<strong>Vivienne van de Walle, Medical Director &#038; Founder, PT&#038;R<br \/>\n                                                                  Bree Burks, VP, Site Solutions Strategy, Veeva<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tIn this week\u2019s episode, Richard Young speaks to Vivienne van de Walle, medical director and founder of PT&#038;R (an independent research site in the Netherlands), and Bree Burks. In this episode, Vivienne and Bree explain the tangible ways that sites (and patients) are hurt by inconsistent technology and the steps to make it better.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_ioau0ndex9 popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s2-e6\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_bwkpak8wne popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/eu\/wp-content\/uploads\/2024\/01\/S2E6-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 6<\/span><\/p>\n<h2>Transforming Clinical Operations: What Comes Next?<\/h2>\n<p>\t\t\t\t\t\t<strong>Emma Earl, Head of Clinical Trial Management Services and Solutions, Bayer<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tIn this episode, Richard Young speaks with Bayer\u2019s Head of Clinical Trial Management Services and Solutions, Emma Earl. Together they outline the major opportunities and the missing ingredients for  delivering efficient and patient-centric clinical trials.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_bwkpak8wne popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s2-e5\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_8wqz51t9sp popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2024\/01\/S2E5-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 5: Special Episode<\/span><\/p>\n<h2>The State of Clinical Trials in the U.K. and Europe<\/h2>\n<p>\t\t\t\t\t\t<strong>Chris Moore, President, Veeva Europe<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tWe have a special episode for you this week! In a twist to our usual format, Nicole Raleigh of Pharmaphorum is in the host seat interviewing Veeva\u2019s Chris Moore about his outlook on clinical trials in the U.K. and Europe.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_8wqz51t9sp popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p><a id=\"s2-e4\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_l4f0xu3aie popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/12\/S2E4-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 4<\/span><\/p>\n<h2>Clinical Data Innovation In A Non-EDC Centric World<\/h2>\n<p>\t\t\t\t\t\t<strong>Patrick Nadolny, global head of clinical data management, Sanofi<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tThis week, Richard Young speaks to Patrick Nadolny, global head of clinical data management, Sanofi.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_l4f0xu3aie popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>                         <a id=\"s2-e3\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_0acw6j67wv popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/11\/Podcast-episode-3.jpeg\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 3<\/span><\/p>\n<h2>Takeaways from Veeva&#8217;s R&#038;D and Quality North America Summit<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Jim Reilly, VP, Development Cloud Strategy, Veeva<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tThey discuss learnings from Veeva\u2019s recent North American R&#038;D and Quality Summit \u2014 including observations and trends from hundreds of biopharmas.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_0acw6j67wv popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s2-e2-se\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_ugk4ncksdp popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/10\/S2SPECIAL_EDITION-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Special Edition<\/span><\/p>\n<h2>Evolution du Data Management Clinique<\/h2>\n<p>\t\t\t\t\t\t<strong>Guests: Vincent Rolland d\u2019Idorsia<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tVincent Rolland d\u2019Idorsia et Fran\u00e7ois Caijo de Veeva, deux passionn\u00e9s de la data clinique,<br \/>\n\t\t\t\t\t\t\t\u00e9changent autour de l\u2019\u00e9volution du Data Management Clinique et se projettent dans l\u2019avenir..\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_ugk4ncksdp popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s2-e2\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_74771myauj popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/10\/State-of-Digital-Clinical-Trials-Podcast-S2-E2_S2E3-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 2<\/span><\/p>\n<h2>Debunking the Myths of AI<\/h2>\n<p>\t\t\t\t\t\t<strong>Guests: Andy Cooper, CEO of Cluepoints<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tDoes ChatGPT understand data from clinical trials? Andy Cooper, CEO of Cluepoints, explains<br \/>\n\t\t\t\t\t\t\twhy<br \/>\n\t\t\t\t\t\t\tindustry context will be critical for the success of AI and machine learning initiatives in<br \/>\n\t\t\t\t\t\t\tclinical data.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_74771myauj popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s2-e1\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_ug4pyyeupc popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/09\/S2E1-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 1<\/span><\/p>\n<h2>Does Patient Choice Equal Site Headaches?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guests: Helen Shaw, Co-Founder and Managing Director, VCTC <br \/> Marie-Claire Flavin,<br \/>\n\t\t\t\t\t\t\tDirector, Customer Success, Veeva Site Solutions (EMEA)<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tThis episode covers novel ways that sites are using technology to expand patient choice in<br \/>\n\t\t\t\t\t\t\tclinical research without compromising operational efficiency.<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_zybw9kejjy popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<div class=\"season-1\">\n<p>\t\t\t<a id=\"s1-e10\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_zybw9kejjy popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2023\/08\/Episode-10-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 10<\/span><\/p>\n<h2>Why We Need to Expand Patient Choice in Clinical Trials<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Tim Davis, Vice President of Strategy for MyVeeva for Patients<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tThis week, Richard Young speaks to Tim Davis, Vice President of Strategy for MyVeeva for<br \/>\n\t\t\t\t\t\t\tPatients. In recent years, decentralized clinical trials, patient centricity, and site<br \/>\n\t\t\t\t\t\t\tcentricity have become buzzwords for sponsors and CROs. But positive change starts with<br \/>\n\t\t\t\t\t\t\texpanding patient choice during clinical trials. <\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_ug4pyyeupc popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e9\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_nebbsj6czu popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/04\/Episode-9-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 9<\/span><\/p>\n<h2>How Can We Prepare for the Future of Clinical Trials?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Rhona O\u2019Donnell, VP, Data Management Systems and Standards at Novo<br \/>\n\t\t\t\t\t\t\tNordisk<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tThis week, Richard Young is joined by Rhona O\u2019Donnell, VP, Data Management Systems and<br \/>\n\t\t\t\t\t\t\tStandards<br \/>\n\t\t\t\t\t\t\tat Novo Nordisk. They discuss the evolution of the data management role, and how we can<br \/>\n\t\t\t\t\t\t\tprepare<br \/>\n\t\t\t\t\t\t\tfor the future through collaboration and more effective training for the next generation.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_nebbsj6czu popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e8\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_j8cyqfywkt popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/04\/Episode-8-website-thumbnail-2.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 8<\/span><\/p>\n<h2>Are We Any Closer to Patient-Centric Trials?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Alan Morgan, CEO Advisor of Excelya<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tThis week, Richard Young speaks to Alan Morgan, CEO Advisor of Excelya. In recent years,<br \/>\n\t\t\t\t\t\t\tsponsors and CROs have invested heavily in \u201cbig data\u201d tools for site selection and<br \/>\n\t\t\t\t\t\t\tproductivity.<br \/>\n\t\t\t\t\t\t\tBut has that investment paid off?\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_j8cyqfywkt popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e7\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_p0hx89q38j popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/eu\/wp-content\/uploads\/2023\/03\/Episode-7-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 7<\/span><\/p>\n<h2>Is Data Management the Glue of Modern Clinical Trials?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Luis E. Torres, Head of Clinical Programming FSPx, Labcorp<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tListen to how data managers can prepare for the future of clinical trials by adopting new<br \/>\n\t\t\t\t\t\t\ttechnologies and skills that will keep decentralized clinical teams connected.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_p0hx89q38j popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e6\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_m68sr35wvd popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2023\/01\/Episode-6-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 6<\/span><\/p>\n<h2>Data Managers: Driving the Future of Clinical Research<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Mayank Anand, VP and Global Head of Data Strategy and Management, GSK<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tIn this week\u2019s conversation, hear how clinical data professionals\u2019 roles are evolving in a<br \/>\n\t\t\t\t\t\t\tworld<br \/>\n\t\t\t\t\t\t\tof decentralized data. It\u2019s a great time to be a clinical data professional, they agree, as<br \/>\n\t\t\t\t\t\t\ta<br \/>\n\t\t\t\t\t\t\tonce invisible role moves front and center to optimize trial protocols, operations, and<br \/>\n\t\t\t\t\t\t\tresults<br \/>\n\t\t\t\t\t\t\tand speed patient access to better treatments.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_m68sr35wvd popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e5\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_qtgdf116k2 popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2022\/12\/Episode-5-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 5<\/span><\/p>\n<h2>How Will RTSM Impact Clinical Data?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Natalie Townsend, VP Strategy, Veeva RTSM<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tRichard Young speaks to Natalie Townsend, the global lead for Randomization and Trial Supply<br \/>\n\t\t\t\t\t\t\tManagement (RTSM) strategy at Veeva. They discuss the evolution of \u2018digital\u2019 clinical trials<br \/>\n\t\t\t\t\t\t\tfrom the early days of phone-based and spreadsheet-centered activities to the role<br \/>\n\t\t\t\t\t\t\ttechnology is<br \/>\n\t\t\t\t\t\t\tplaying today.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_qtgdf116k2 popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e4\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_z4dkt9eioj popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2022\/12\/Episode-4-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 4<\/span><\/p>\n<h2>How Clean is Your Data?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Trevor Griffiths, Senior Director for Clinical Data Management, Syneos<br \/>\n\t\t\t\t\t\t\tHealth<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tRichard Young speaks to Trevor Griffiths, senior director for clinical data management at<br \/>\n\t\t\t\t\t\t\tSyneos<br \/>\n\t\t\t\t\t\t\tHealth. Data management is becoming much more complex for CROs, as trials become larger and<br \/>\n\t\t\t\t\t\t\tdata<br \/>\n\t\t\t\t\t\t\tsources more diverse.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_z4dkt9eioj popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e3\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_so7ytm2t4c popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2022\/12\/Episode-3-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 3<\/span><\/p>\n<h2>Will Traditional EDC Exist 10 Years From Now?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Doug Bain, Chief Technology Office, KCR<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tRichard Young speaks to Doug Bain, chief technology officer at KCR, a contract research<br \/>\n\t\t\t\t\t\t\torganization (CRO). They discuss the role of electronic data capture (EDC) in today\u2019s<br \/>\n\t\t\t\t\t\t\tcomplex,<br \/>\n\t\t\t\t\t\t\tdynamic clinical trial landscape.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_so7ytm2t4c popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e2\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_keicffvzbn popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2022\/12\/Episode-2-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 2<\/span><\/p>\n<h2>What Should Be in Your Digital Trial Toolkit?<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Tanya du Plessis, Chief Data Strategist and Solutions Officer, Bioforum<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tRichard Young speaks to Tanya du Plessis, chief data strategist and solutions officer at<br \/>\n\t\t\t\t\t\t\tBioforum the Data Masters, a data-focused CRO. The old days of linear trial processes and<br \/>\n\t\t\t\t\t\t\tpushing paper are thankfully over, presenting exciting opportunities in clinical data<br \/>\n\t\t\t\t\t\t\tmanagement.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_keicffvzbn popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<p>\t\t\t<a id=\"s1-e1\" class=\"scrolldown\"><\/a><\/p>\n<div class=\"row d-flex mb-50\">\n<div class=\"col-sm-5 col-md-4\">\n\t\t\t\t\t<span class=\"wistia_embed wistia_async_4yc0v0e2f3 popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"\/wp-content\/uploads\/2022\/12\/Episode-1-website-thumbnail.png\"><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<div class=\"col-sm-7 col-md-8 text-left text-box\">\n<div class=\"text\">\n\t\t\t\t\t\t<span>Episode 1<\/span><\/p>\n<h2>Life Sciences in Europe: Breaking Down the Barriers<\/h2>\n<p>\t\t\t\t\t\t<strong>Guest: Chris Moore, President, Veeva Europe<\/strong><\/p>\n<p>\n\t\t\t\t\t\t\tAfter more than two years apart, European life sciences came together in Zurich in June.<br \/>\n\t\t\t\t\t\t\tThere<br \/>\n\t\t\t\t\t\t\tare big advances underway that will make clinical research faster, better connected, and<br \/>\n\t\t\t\t\t\t\tmore<br \/>\n\t\t\t\t\t\t\tpatient-centric. But there\u2019s also frustration at the silo-driven approach.\n\t\t\t\t\t\t<\/p>\n<\/p><\/div>\n<p>\t\t\t\t\t<span class=\"wistia_embed wistia_async_4yc0v0e2f3 popover=true popoverContent=link\"><br \/>\n\t\t\t\t\t\t<a class=\"after-arrow-orange\">Watch Video<\/a><br \/>\n\t\t\t\t\t<\/span>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n<div class=\"product-container dct\" style=\"background-color:#F2F2F2\">\n<div class=\"container\">\n<div class=\"row text-left\">\n<div class=\"col-sm-3\">\n\t\t\t\t<img decoding=\"async\" class=\"img-responsive\" alt=\"\" src=\"https:\/\/www.veeva.com\/wp-content\/uploads\/2024\/10\/Manny-Vazquez.png\">\n\t\t\t<\/div>\n<div class=\"col-sm-9\">\n<p class=\"main-txt\">\n\t\t\t\t\t<strong>Unblinded: A Clinical Trial Podcast<\/strong> is a Veeva podcast hosted by Manny Vazquez, Senior Director, Clinical Data Strategy. Manny will be speaking to a series of expert guests from across pharma, biotech, and CROs to discuss their experiences, challenges, and ideas for the future of clinical trials.\n\t\t\t\t<\/p>\n<hr>\n<p>\n\t\t\t\t<strong><br \/>\n\t\t\t\tSubscribe to <strong>Unblinded: A Clinical Trial Podcast<\/strong>, a Veeva podcast to get new episodes as soon as they are released.<br \/>\n\t\t\t\t<\/strong>\n\t\t\t\t<\/p>\n<div class=\"icons\">\n\t\t\t\t\t<img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/12\/Spotify-icon.png\"><a target=\"_blank\" href=\"https:\/\/open.spotify.com\/show\/2zIGPSf4Uw3s7qOHA39ykD\" rel=\"noopener\">Spotify<\/a><br \/>\n\t\t\t\t\t<img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/12\/Apple-podcast.png\"><a target=\"_blank\" href=\"https:\/\/podcasts.apple.com\/us\/podcast\/state-of-digital-clinical-trials-podcast\/id1634250410\" rel=\"noopener\">Apple Podcasts<\/a> <br \/>\n\t\t\t\t\t<img decoding=\"async\" src=\"\/wp-content\/uploads\/2022\/12\/YouTube-Icon.png\"><a target=\"_blank\" href=\"https:\/\/www.youtube.com\/playlist?list=PLPRDETVDFr08j0kP0dEWL32z4_0JsiviT\" rel=\"noopener\">Youtube<\/a>\n\t\t\t\t<\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>State of Digital Clinical Trials<\/p>\n","protected":false},"author":42,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"templates\/template-full-page.php","meta":{"footnotes":""},"coauthors":[],"class_list":["post-68844","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/68844"}],"collection":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/users\/42"}],"replies":[{"embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/comments?post=68844"}],"version-history":[{"count":24,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/68844\/revisions"}],"predecessor-version":[{"id":94978,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/pages\/68844\/revisions\/94978"}],"wp:attachment":[{"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=68844"}],"wp:term":[{"taxonomy":"author","embeddable":true,"href":"https:\/\/pantheon.veeva.com\/eu\/wp-json\/wp\/v2\/coauthors?post=68844"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}